Xiao Zheng

8PUBLICATIONS
12CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 11, 2026
A Comprehensive Review of AIM2 in Cancer: Functional Roles, Molecular Pathways, and Clinical Relevance.

Nuo Wang, Shaoxian Wu, Zhang Fang

|Feb 03, 2026
Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy.

Zekang Li, Xiao Zheng, Han Xia

|Dec 09, 2025
IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.

Lujun Chen, Hongwei Jiang, Bo Tan

|Aug 22, 2024
NUP37 promotes the proliferation and invasion of glioma cells through DNMT1-mediated methylation.

Yongqiang Lv, Chaolian Wang, Ruoyu Liu

|Jun 03, 2024
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells.

Zhang Fang, Xinyi Ding, Hao Huang

|Apr 02, 2024
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.

Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu

Pageof 2

Frequent Collaborators

2 joint publications

Jingting Jiang

1 joint publications

You Zhou

1 joint publications

Yufang Shi

1 joint publications

Pengcheng Sun